Report #2894524

Overview

Sex

Female

Age

Age unknown

State

NE

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

residents in a long-term care facility may have received the ADJUVANT only for AREXVY; HCP states there is no way to determine if the medication was correctly administered or if there was a medication error; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced inappropriate preparation of medication (Verbatim: residents in a long-term care facility may have received the ADJUVANT only for AREXVY) and inappropriate dose of vaccine administered (Verbatim: HCP states there is no way to determine if the medication was correctly administered or if there was a medication error). Additional Information: GSK Receipt Date: 17-APR-2026 The batch number was not provided upon follow- up with the reporter.; Sender's Comments: US-GSK-US2026AMR057032:Same Reporter DIFFERENT patient